Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Am Coll Surg ; 235(6): 906-912, 2022 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-36102508

RESUMO

BACKGROUND: Intraoperative parathyroid hormone (IOPTH) testing facilitates focused parathyroidectomy to establish biochemical cure but may be time-consuming. A dedicated immunoassay machine was relocated to the operating room for IOPTH. These data seek to determine association of operating room-based IOPTH with operative time, laboratory turnaround time (TAT), and cost. METHODS: Patients who underwent parathyroidectomy from June 2017 to February 2020 were reviewed. Clinical and demographic data, operative time, and TAT were collected. Patients were compared by operation dates pre- or post-machine acquisition. A cost model was created to evaluate cost of care before and after operating room-based testing. RESULTS: A total of 285 patients were included. Post-machine, median operative time decreased from 69 minutes (interquartile range [IQR] 60 to 84) to 57 minutes (IQR 50 to 84.5), p 0.03. Additionally, median TAT for IOPTH values (preoperative, 0, 5, 10, and 15 minutes) decreased post-machine: time preoperative, 29 minutes (IQR 23 to 40) vs 18 minutes (IQR 17 to 23.5), p < 0.001; time 0, 33 minutes (IQR 27 to 39) vs 18.5 minutes (17.5 to 21), p < 0.001; time 5 minutes, 31 minutes (IQR 26 to 36) vs 20 minutes (IQR 18.5 to 21), p < 0.001; time 10 minutes, 32 minutes (IQR 27 to 39) vs 20 minutes (IQR 18.5 to 22.5), p < 0.001; and time 15 minutes, 30 minutes (IQR 26 to 36) vs 19 minutes (IQR 17 to 21), p < 0.001. Total costs pre- and post-machine were $4,442 and $4,111, respectively. With $331 cost reduction per operation and 127 operations per year, the IOPTH machine pays for itself in 3 years, or 378 surgeries, and saves $168,589 in the machine's remaining 4-year life span. CONCLUSIONS: Operating room-based parathyroid hormone testing results in improved operating productivity by decreasing result TAT and operative time and reduces cost.


Assuntos
Hiperparatireoidismo Primário , Salas Cirúrgicas , Humanos , Duração da Cirurgia , Monitorização Intraoperatória/métodos , Hormônio Paratireóideo , Paratireoidectomia/métodos , Hiperparatireoidismo Primário/cirurgia , Estudos Retrospectivos
2.
Ann Surg Oncol ; 23(5): 1440-5, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-26628433

RESUMO

BACKGROUND: Concern for postoperative complications causing airway compromise has limited widespread acceptance of ambulatory thyroid surgery. We evaluated differences in outcomes and hospital costs in those monitored for a short stay of 6 h (SS), inpatient observation of 6-23 h (IO), or inpatient admission of >23 h (IA). METHODS: We retrospectively reviewed all patients undergoing thyroidectomy from 2006 to 2012. The incidence of postoperative hemorrhage, nerve dysfunction, and hypocalcemia were evaluated, as well as cost data comparing the SS and IO groups. RESULTS: Of 1447 thyroidectomies, 880 (60.8 %) were performed as SS, 401 (27.7 %) as IO, and 166 (11.5 %) as IA. Fewer patients in the SS group (59 %) underwent total thyroidectomy than IO (73 %) and IA (71 %; p < 0.01), and SS patients had smaller thyroid weights (27.9 g) compared with IO and IA (47.2 and 98.9 g, respectively; p < 0.01). Ten (0.69 %) patients developed hematomas requiring reoperation, five of the ten patients received antiplatelet or anticoagulant therapy perioperatively. Only one patient in the IA group bled within the 6- to 23-h period, and no patients with bleeding who were discharged at 6 h would have benefitted from 23-h observation. Twenty-four (1.66 %) recurrent laryngeal nerve injuries were identified, 16 with temporary neuropraxias. In addition, 24 (1.66 %) patients had symptomatic hypocalcemia, which was transient in 17 individuals. Financial data showed higher payments and lower costs associated with SS compared with IO. CONCLUSIONS: Selective SS thyroidectomy can be safe and cost effective, with few overall complications in patients undergoing more complex operations involving larger thyroids who were admitted to hospital.


Assuntos
Hemorragia/economia , Hipocalcemia/economia , Complicações Pós-Operatórias/economia , Doenças da Glândula Tireoide/cirurgia , Tireoidectomia/economia , Adulto , Idoso , Feminino , Seguimentos , Hemorragia/diagnóstico , Hemorragia/etiologia , Humanos , Hipocalcemia/diagnóstico , Hipocalcemia/etiologia , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Prognóstico , Estudos Retrospectivos , Doenças da Glândula Tireoide/economia , Tireoidectomia/efeitos adversos
3.
Am J Infect Control ; 30(6): 351-4, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12360144

RESUMO

Medication-related errors are a common cause of patient morbidity and mortality. However, a number of strategies use the latest technology, such as computers and associated hardware and software, to reduce medication-related errors. In this era of reduced operating margins for most hospitals, strategies that employ physician order entry and bar code-labeled medication systems may be prohibitively expensive. Cost-efficient methods are available that can make simple changes in the way medications are mixed, stored, prescribed, and delivered, and they have the potential to have a major effect on medication safety. These methods do not rely on purchasing new hardware or expensive software. They include changing the culture within the hospital to one that focuses on patient safety, developing standardized protocols, developing an education program that provides direct feedback, and using protocols for high-risk medications. Coordinating hospital efforts with regional organizations may also be beneficial in reducing the occurrence of medication-related errors.


Assuntos
Erros de Medicação/economia , Erros de Medicação/prevenção & controle , Protocolos Clínicos/normas , Análise Custo-Benefício , Prescrições de Medicamentos/normas , Armazenamento de Medicamentos/normas , Administração Hospitalar/normas , Humanos , Educação de Pacientes como Assunto , Farmacêuticos/organização & administração , Farmacêuticos/normas , Farmacêuticos/estatística & dados numéricos , Serviço de Farmácia Hospitalar/organização & administração , Cloreto de Potássio , Segurança/economia , Software
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA